A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

NCT05636319 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

14168

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: ABO1020
BIOLOGICAL: Placebo

Sponsor

Suzhou Abogen Biosciences Co., Ltd.